{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:05:29Z","timestamp":1770977129724,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"11","funder":[{"name":"Wellcome Trust","award":["WT093722MA"],"award-info":[{"award-number":["WT093722MA"]}]},{"name":"Wellcome Trust","award":["170461"],"award-info":[{"award-number":["170461"]}]},{"DOI":"10.13039\/501100000841","name":"British Infection Society","doi-asserted-by":"crossref","award":["E19115"],"award-info":[{"award-number":["E19115"]}],"id":[{"id":"10.13039\/501100000841","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institutes for Health Research University College London Hospitals Biomedical Research Centre"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Antimicrob. Chemother."],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1093\/jac\/dkw265","type":"journal-article","created":{"date-parts":[[2016,7,12]],"date-time":"2016-07-12T01:53:27Z","timestamp":1468288407000},"page":"3228-3234","source":"Crossref","is-referenced-by-count":11,"title":["Virological efficacy of PI monotherapy for HIV-1 in clinical practice"],"prefix":"10.1093","volume":"71","author":[{"given":"Kate","family":"El Bouzidi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dami","family":"Collier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Nastouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Copas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert F.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravindra K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2016,7,7]]},"reference":[{"key":"2016102607352770000_71.11.3228.1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jit112"},{"key":"2016102607352770000_71.11.3228.2","doi-asserted-by":"publisher","DOI":"10.1086\/503914"},{"key":"2016102607352770000_71.11.3228.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506816"},{"key":"2016102607352770000_71.11.3228.4","unstructured":"WHO. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV . 2015. http:\/\/apps.who.int\/iris\/bitstream\/10665\/186275\/1\/9789241509565_eng.pdf?ua=1 ."},{"key":"2016102607352770000_71.11.3228.5","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(15)00176-9"},{"key":"2016102607352770000_71.11.3228.6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dks540"},{"key":"2016102607352770000_71.11.3228.7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2012.00989.x"},{"key":"2016102607352770000_71.11.3228.8","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr504"},{"key":"2016102607352770000_71.11.3228.9","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq327"},{"key":"2016102607352770000_71.11.3228.10","doi-asserted-by":"publisher","DOI":"10.1310\/hct1006-368"},{"key":"2016102607352770000_71.11.3228.11","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3282f4243b"},{"key":"2016102607352770000_71.11.3228.12","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000180077.59159.f4"},{"key":"2016102607352770000_71.11.3228.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2009.00752.x"},{"issue":"Suppl 3","key":"2016102607352770000_71.11.3228.14","doi-asserted-by":"crossref","first-page":"19525","DOI":"10.7448\/IAS.17.4.19525","article-title":"The PROTEA trial: darunavir\/ritonavir with or without nucleoside analogues, for patients with HIV-1 RNA below 50 copies\/mL","volume":"17","author":"Antinori","year":"2014","journal-title":"J Int AIDS Soc"},{"key":"2016102607352770000_71.11.3228.15","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000407"},{"key":"2016102607352770000_71.11.3228.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311274"},{"key":"2016102607352770000_71.11.3228.17","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3181e47609"},{"key":"2016102607352770000_71.11.3228.18","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dku509"},{"key":"2016102607352770000_71.11.3228.19","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkt517"},{"key":"2016102607352770000_71.11.3228.20","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e32835646e0"},{"key":"2016102607352770000_71.11.3228.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037442"},{"key":"2016102607352770000_71.11.3228.22","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm198"},{"key":"2016102607352770000_71.11.3228.23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148924"},{"key":"2016102607352770000_71.11.3228.24","unstructured":"European AIDS Clinical Society. Clinical Management and Treatment of HIV Infected Adults in Europe, Version 5 . 2009. http:\/\/www.eacsociety.org\/files\/2009_eacsguidelines-v5-english.pdf ."},{"key":"2016102607352770000_71.11.3228.25","doi-asserted-by":"crossref","unstructured":"Panel de Expertos de Gesida y Plan Nacional Sobre el Sida. Recomendaciones de Gesida\/Plan Nacional sobre el Sida Respecto al Tratamiento Antirretroviral en Adultos Infectados por el VIRUS de la Inmunodeficiencia Humana. 2009. http:\/\/www.gesida-seimc.org\/contenidos\/guiasclinicas\/2009\/gesidadcyrc2009_RecomendacionesdeGesida-PNSsobreTARV.pdf .","DOI":"10.1016\/j.eimc.2008.11.002"},{"key":"2016102607352770000_71.11.3228.26","unstructured":"Rapport 2010 Sous la Direction du Pr.: Patrickyeni. Prise en Charge M\u00e9dicale des Personnes Infect\u00e9es par le VIH . Minist\u00e8re de la Sant\u00e9 et des Sports. http:\/\/www.sante.gouv.fr\/IMG\/pdf\/Rapport_2010_sur_la_prise_en_charge_medicale_des_personnes_infectees_par_le_VIH_sous_la_direction_du_Pr-_Patrick_Yeni.pdf ."},{"key":"2016102607352770000_71.11.3228.27","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.17.1.19034"},{"key":"2016102607352770000_71.11.3228.28","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.12119"},{"key":"2016102607352770000_71.11.3228.29","unstructured":"British HIV Association. British HIV Association Guidelines for the Treatment of HIV-1-Positive Adults with Antiretroviral Therapy 2015 . http:\/\/www.bhiva.org\/documents\/Guidelines\/Treatment\/2015\/2015-treatment-guidelines.pdf ."},{"key":"2016102607352770000_71.11.3228.30","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e328270389b"},{"key":"2016102607352770000_71.11.3228.31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit933"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/71\/11\/3228\/7939811\/dkw265.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,17]],"date-time":"2020-05-17T01:09:20Z","timestamp":1589677760000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkw265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,7]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,10,21]]},"published-print":{"date-parts":[[2016,11]]}},"alternative-id":["10.1093\/jac\/dkw265"],"URL":"https:\/\/doi.org\/10.1093\/jac\/dkw265","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,7]]}}}